Agilent Technologies (A) Change in Accured Expenses (2009 - 2026)
Agilent Technologies (A) posted quarterly Change in Accured Expenses of -$48.0 million for Q2 2026, down 500.0% year-over-year from $12.0 million in Q2 2025, and down 336.36% quarter-over-quarter from -$11.0 million in Q1 2026.
Agilent Technologies (A) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Change in Accured Expenses for 18 consecutive years, with -$48.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 500.0% year-over-year to -$48.0 million; the TTM figure through Apr 2026 stood at $10.0 million (up 11.11% YoY), while the FY2025 annual figure was $69.0 million, up 675.0% from the prior year.
- Change in Accured Expenses fell to -$48.0 million in Q2 2026 per A's latest filing, from -$11.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $166.0 million in Q2 2023 and bottomed at -$210.0 million in Q1 2022.
- Historically, Change in Accured Expenses has averaged -$1.1 million across 5 years, with a median of -$6.5 million in 2024.
- Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 151.52% — and 2026, when it sank 500.0%.
- Agilent Technologies' Change in Accured Expenses stood at $76.0 million in 2022, then surged by 85.53% to $141.0 million in 2023, then plunged by 62.41% to $53.0 million in 2024, then soared by 79.25% to $95.0 million in 2025, then plunged by 150.53% to -$48.0 million in 2026.
- Business Quant data shows A's Change in Accured Expenses at -$48.0 million in Q2 2026, -$11.0 million in Q1 2026, and $95.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -39.33 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 92.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -24.00 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 142.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 92.00 Mn |
| Apr 30, 2026 | 92.00 Mn |
| Jan 31, 2026 | -151.00 Mn |
| Jan 31, 2026 | -151.00 Mn |
| Oct 31, 2025 | 95.00 Mn |
| Oct 31, 2025 | 95.00 Mn |
| Jul 31, 2025 | -1.00 Mn |
| Jul 31, 2025 | -1.00 Mn |
| Apr 30, 2025 | 79.00 Mn |
| Apr 30, 2025 | 79.00 Mn |
| Jan 31, 2025 | -104.00 Mn |
| Jan 31, 2025 | -104.00 Mn |
| Oct 31, 2024 | 53.00 Mn |
| Oct 31, 2024 | 53.00 Mn |
| Jul 31, 2024 | -18.00 Mn |
| Jul 31, 2024 | -18.00 Mn |
| Apr 30, 2024 | 57.00 Mn |
| Apr 30, 2024 | 57.00 Mn |
| Jan 31, 2024 | -104.00 Mn |
| Jan 31, 2024 | -104.00 Mn |